Investor Relations News: Breaking Investor Relations News, Comments and Articles. - Page: 2

Royalty beißt sich bei Elan fest: Übernahmeangebot auf 12,50 Dollar erhöht

Der Investor Royalty Pharma lässt sich von Elan nicht abschütteln: Die Amerikaner erhöhten ihr Übernahmeangebot für das irische Biotechunternehmen trotz dessen erbitterten Widerstands auf 12,50 US...

Medtronic to Honor Those Who Give Back After Receiving Life-Enhancing Medical Technology

(View the Bakken Invitation video here) Live On. Give On:  Ten inspirational people will be awarded a $20,000 charitable donation and be honored at an awards celebration in Hawaii as part of the first annual Bakken Invitation MINNEAPOLIS - May 20, 2013- Medtronic, Inc. (NYSE: MDT) announced today that applications are being accepted for the inaugural Bakken Invitation, a global program desig...

Royalty Pharma ups offer for Elan to $12.50/shr

LONDON, May 20 (Reuters) - U.S. investor Royalty Pharma raised its offer to $12.50 per share for Irish drugmaker Elan on Monday, representing a premium of 45 percent to Elan's enterprise value, it said.

Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013

MINNEAPOLIS, May 20, 2013 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI) announced today that it will release financial results for the fiscal fourth quarter and full year ended March 31, 2013 at the market close on Thursday, May 30, 2013. The Company will host a conference call and webcast to discuss these results on Thursday, May 30, 2013 at 4:30 p.m. Eastern Time (3:30 p.m. Cent...

Actavis, Inc., Warner Chilcott plc - M&A Call

Actavis, Inc. (ACT) May 20, 2013 8:00 am ET Executives Lisa M. Defrancesco - Former Vice President of Global Investor Relations Paul M. Bisaro - Chief Executive Officer, President and Director Roger M. Boissonneault - Chief Executive Officer, President and Director George Frederick Wilkinson - President of Global Brands and Biosimilars R. Todd Joyce - Global Chief Financial Officer Sigurdur O...

Actavis' CEO Hosts Acquisition of Warner Chilcott Conference (Transcript)

Actavis, Inc. (ACT)CEO Hosts Acquisition of Warner Chilcott Conference May 20, 2013 8:00 am ET Executives Lisa M. Defrancesco - Former Vice President of Global Investor Relations Paul M. Bisaro - Chief Executive Officer, President and Director Roger M. Boissonneault - Chief Executive Officer, President and Director George Frederick Wilkinson - President of Global Brands and Biosimilars R. Tod...

Cantel Medical To Present At The Deutsche Bank 38th Annual Health Care Conference

LITTLE FALLS, N.J., May 20, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Deutsche Bank 38th Annual Health Care Conference at the Westin Boston Waterfront Hotel in Boston, Massachusetts. The formal presentation is scheduled for Wednesday, May 29, 2013 at 10:00 AM EDT with a Q & A session immedi...

WellCare Medicare Advantage Members Now Covered At Walgreens Take Care Clinics

TAMPA, Fla. (May 20, 2013) - WellCare Health Plans, Inc. (NYSE: WCG) recently entered into an agreement with Take Care Health Systems, a subsidiary of Walgreens (NYSE, Nasdaq: WAG), to offer its Medicare Advantage members access to the more than 370 Take Care Clinics located at select Walgreens stores in 19 states and Washington, D.C.  As of March 2013, WellCare serves more than 256,000 Medic...

XenoPort's CEO Presents at Special Conference (Transcript)

XenoPort, Inc. (XNPT) Special Conference Call May 20, 2013 8:30 am ET Executives Jackie Cossmon – Investor Relations Ronald W. Barrett – Chief Executive Officer William G. Harris – Senior Vice President of Finance and Chief Financial Officer Vincent J. Angotti – Executive Vice President and Chief Operating Officer Analysts Rebecca M. Forest – Piper Jaffray, Inc. Brian C. Abrah...

Pacific Shore Holdings Retains Investor Relations Firm

CHATSWORTH, Calif., May 20, 2013 /PRNewswire/ -- (PSHR) Pacific Shore Holdings, Inc. a consumer products company providing naturally based products across a broad range of product categories lines, today reports that the company has retained investor relations firm, BlueWater Advisory Group, to provide strategic counsel and guidance during the return to trading process, and to direct the comp...

Humana Names Tracie Fahy to Lead North Florida Medicare Market Operations

CarePlus Health Plans chief operating officer tapped to head key North Florida market Humana Inc. (NYSE: HUM) announced today that Tracie Fahy, formerly Chief Operating Officer for Humana Florida Medicare Advantage HMO CarePlus Health Plans, has been appointed Regional Market Vice President for Humana’s North Florida Medicare market operations....

Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AM

Illumina, Inc. (ILMN) May 20, 2013 11:30 am ET Executives Marc A. Stapley - Chief Financial Officer and Senior Vice President Analysts Daniel Arias - UBS Investment Bank, Research Division Presentation Daniel Arias - UBS Investment Bank, Research Division Okay. Welcome again. I'm Dan Arias. I'm the life sciences analyst at UBS. I'm going to ahead and introduce our next company to p...

MusclePharm to Present at B. Riley & Co. 14th Annual Investor Conference on Monday, May 20th at 1:00 pm PDT

DENVER, CO -- (Marketwired) -- 05/20/13 -- MusclePharm Corporation (OTCQB: MSLP), a fast growing company that develops and markets sports nutritional supplements which address active lifestyles, an...

Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare Conference (Transcript)

Start Time: 09:30 End Time: 09:51 Gilead Sciences, Inc. (GILD) Company Conference Presentation May 20, 2013, 09:30 AM ET Executives Robin L. Washington - SVP and CFO Analysts Matthew Roden - UBS Presentation Matthew Roden - UBS Good morning, everyone. My name is Matt Roden. I'm one of the biotech analysts here at UBS and I'd like to thank everyone for attending our new UBS Global H...

Medtronic Receives 'CE' Mark for 'Export Advance' Aspiration Catheter

Backed by Robust Clinical Data on Broad Product Family, New Thrombus Removal System Offers Superior Deliverability MINNEAPOLIS -- May 20, 2013 -- Expanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) announced today that the Export Advance aspiration catheter recently received the CE (Conformité Européenne) mark...

A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013

By A John Hodge:In January, I wrote an article on regenerative medicine companies that could make headway in 2013. I would like to refocus on the subject and review some of my favorite candidates in the young, but quickly growing industry of regenerative medicine. The subject matter has worldwide appeal and relevance, as everyone on the planet can benefit from it. As a patient, regenerative medici...

Impax Laboratories to Present at the UBS Global Healthcare Conference

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Healthcare Conference on Wednesday, May 22, at 9:00 a.m. Eastern Standard Time. The conference will be held at the Sheraton New York Hotel. Individuals may listen to the live or an archived presentation made at the conference, which will be post...

Synageva's Sebelipase Alfa Receives Breakthrough Therapy Designation for Early Onset LAL Deficiency from the U.S. Food and Drug Administration

Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency (LAL Deficiency), also known a...

HBMA Supports New Healthcare Simplification Programs

Healthcare Billing and Management Association finds ways to eliminate administrative redundancies LOS ANGELES, May 20, 2013 /PRNewswire-USNewswire/ -- In the healthcare industry, saving time means saving money for everyone involved in the lifecycle of a medical claim.  The most influential revenue cycle management association, Healthcare Billing & Management Association (HBMA.o...

Amarantus to Present at the 2nd Annual Marcum MicroCap Conference on May 30

SUNNYVALE, Calif., May 20, 2013 /PRNewswire/ -- Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced that Chief Executive Officer Gerald Commissiong will present at the 2nd Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at the...

Cord Blood America, Inc. Announces New Service Offering

SALT LAKE CITY, May 20, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced the launch of a new service offering for the storage of mesenchymal cells through its wholly owned subsidiary CorCell Companies, Inc. (CorCell). For additional information on the new service offering please visit our cord tissue web...

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company

PARSIPPANY, N.J. and DUBLIN, May 20, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion.  If successfully completed, the transaction will create a leading global specialty pha...

Affymetrix Appoints Gavin Wood as Executive Vice President and Chief Financial Officer

A seasoned financial leader with extensive international experience Affymetrix, Inc. (NASDAQ: AFFX) today announced it has appointed Mr. Gavin Wood to the position of Executive Vice President and Chief Financial Officer. Mr. Wood joined Affymetrix in 2006 and served most recently as VP Finance, International Controller based in the United Kingdom....

Elan strikes more deals to repel Royalty bid

DUBLIN (Reuters) - Elan announced its second major drug deal inside a week on Monday and said it would buy back more shares as it continues to bat against a $5.7 billion takeover bid from U.S. investor Royalty Pharma.

Register Today for the Corporate Impact Conference

This is One Conference You Don’t Want to Miss! Sign Up Today! SOURCE: American Cancer Society DESCRIPTION:Tackle the most intriguing topics and issues in your workplace and profession in the American Cancer Society Corporate Impact Conference’s engaging, information-packed sessions that are broken into three tracts: Marketing, Corporate Citizenship, and Health and Wellness. These intimate work...